Alk­er­mes, Te­va set­tle patent suit around opi­oid-block­er Viv­it­rol, paving way for gener­ics af­ter three-year fight

Alk­er­mes has agreed to give Te­va a li­cense to make a gener­ic ver­sion of its opi­oid-block­ing drug Viv­it­rol in or­der to stop patent lit­i­ga­tion that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.